Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus ketamine for analgesia during burn dressing changes
ACTRN12612000700831Phase 4Recruiting
- Sponsor
- JIPMER
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine and ketamine in burn injury (2 arms), sponsored by JIPMER. Primary endpoint: Analgesia during dressing assessed using visual analogue scale. Started Aug 2010; status: recruiting.
02
Drugs
dexmedetomidineketamine
03
Conditions
burn injury
Beyond the preview
Go deeper on ACTRN12612000700831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000700831.